Introduction
Anti-glutamic acid decarboxylase(GAD) are associated with various
neurologic conditions, including stiff person syndrome, cerebellar
ataxia, and limbic/extra-limbic encephalitis, seizure, cognitive
impairment and behavioral disturbance(1–3). Growing evidence reveals
the association of autoimmune meningoencephalitis with Covid-19
infection(4). Here we report a patient with anti-GAD65 autoimmune
meningoencephalitis, post Covid-19 infection.